SALT LAKE CITY–(BUSINESS WIRE)– XableCath, a clinical stage medical device company, announced its XableCath blunt tip support catheter has received clearance from the FDA. The blunt tip catheter facilitates true lumen passage of lesions, both above and below the knee, in the peripheral vasculature. Procedures using the XableCath blunt tip catheters can […]
Other News
Avinger Secures Waiver and Consent to CRG Loan Agreement
REDWOOD CITY, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the Lumivascular approach to treating vascular disease, announced today it has entered into an agreement with CRG to waive […]
Abbott Raising Quarterly Dividend for 46th Straight Year
ABBOTT PARK, Ill., Dec. 15, 2017 /PRNewswire/ — The board of directors of Abbott (NYSE: ABT) today increased the company’s quarterly common dividend to 28 cents per share from 26.5 cents per share. This marks the 376th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Feb. 15, 2018, to shareholders of record at […]
Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc.(NYSE American: CVRS), a leading developer of precision vascular robotics, announced today the first commercial installation of a CorPath GRX System outside of the United States. The system was purchased by the Apex Heart Institute in Ahmedabad, India, a state of the art cardiology center. […]
Centers Commence Enrollment in KNOCOUT PE Study to Measure the Impact of Shorter, Even Safer EKOS® Therapy Protocols for Pulmonary Embolism
BOTHELL, Wash.–(BUSINESS WIRE)–BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients are benefitting from a new standard of care in the treatment of Pulmonary Embolism utilizing EKOS® therapy with faster, and even […]
Saranas Named Finalist for Prestigious International Cardiovascular Innovation Award
HOUSTON–(BUSINESS WIRE)–Saranas, a medical device company with a new technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced the company was named as one of the Top 4 Innovators at the International Conference for Innovations in Cardiovascular Systems (ICI) in Tel Aviv, Israel. The ICI […]
Bay Area’s Bay Labs Completes $5.5M Series A Funding Round
SAN FRANCISCO–(BUSINESS WIRE)– Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced it completed $5.5 million in financing. The Series A round was led by existing investor Khosla Ventureswith participation from new investors including Data Collective (DCVC), Greenbox Venture Partners, Minneapolis Heart Institute Ventures and Georges Harik. […]
Cibiem Appoints William H. Kucheman to the Board of Directors
LOS ALTOS, Calif.–(BUSINESS WIRE)– Cibiem, a clinical-stage medical device company targeting the carotid body to treat diseases like hypertension and heart failure, today announced that industry veteran William H. (Hank) Kucheman has joined its board of directors. Mr. Kucheman’s addition expands Cibiem’s number of directors to seven as he joins independent […]
HeartFlow Announces Decision by HCSC and Additional BlueCross BlueShield Companies to Issue New Positive Medical Policies for Non-Invasive HeartFlow FFRct Analysis
REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow today announced that Health Care Service Corporation (HCSC), which operates Blue Cross and Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and Texas, has issued a medical policy for the HeartFlow® FFRct Analysis, a first-of-its-kind non-invasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). HCSC […]
HeartFlow: Using AI to Recognize Heart Disease Fast
by Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) Med-tech company HeartFlow is using AI and machine learning to combat heart disease. It’s estimated that coronary artery disease is the root cause of nearly 9 million deaths each year. Heart disease is difficult to diagnose because the best test for it was a heart […]



